1. Millett GA, Crowley JS, Koh H, et al. A way forward: the national HIV/AIDS strategy and reducing HIV incidence in the United States: JAIDS J Acquir Immune Defic Syndr. 2010;55:S144–7. https://doi.org/10.1097/QAI.0b013e3181fbcb04.
2. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014–2018. HIV Surveillance Supplemental Report 2020;25(No. 1). Published May 2020. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-1.pdf. Accessed 4 May 2020.
3. Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Updated); vol. 31. Published May 2020. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-31.pdf. Accessed 4 May 2020
4. Gallagher T, Link L, Ramos M, Bottger E, Aberg J, Daskalakis D. Self-perception of HIV risk and candidacy for pre-exposure prophylaxis among men who have sex with men testing for HIV at commercial sex venues in New York City. LGBT Health. 2014;1(3):218–24. https://doi.org/10.1089/lgbt.2013.0046.
5. Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences. 2019 Massachusetts HIV/AIDS Epidemiologic Profile, Statewide Report. Published March 2020. https://www.cdc.gov/hiv/pdf/policies/profiles/cdc-hiv-massachusetts-PrEP.pdf. Accessed 4 May 2020.